Amylyx Pharmaceuticals (AMLX) Operating Leases (2022 - 2026)
Amylyx Pharmaceuticals (AMLX) posted quarterly Operating Leases of $4.5 million for Q1 2026, up 1268.81% year-over-year from $327000.0 in Q1 2025, and down 4.73% quarter-over-quarter from $4.7 million in Q4 2025.
Amylyx Pharmaceuticals (AMLX) Operating Leases (2022 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Operating Leases history runs 5 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Operating Leases rose 1268.81% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 1268.81% YoY), while the FY2025 annual figure was $4.7 million, up 914.69% from the prior year.
- Operating Leases for Q1 2026 stood at $4.5 million, down from $4.7 million in the prior quarter.
- The five-year high for Operating Leases was $5.8 million in Q1 2022, with the low at $327000.0 in Q1 2025.
- The 5-year median for Operating Leases is $4.2 million (2022), against an average of $3.5 million.
- The sharpest annual moves came in 2024 and 2026: Operating Leases sank 76.62% in 2024, then surged 1268.81% in 2026.
- Amylyx Pharmaceuticals' Operating Leases stood at $4.2 million in 2022, then slumped by 53.27% to $2.0 million in 2023, then slumped by 76.62% to $463000.0 in 2024, then jumped by 914.69% to $4.7 million in 2025, then retreated by 4.73% to $4.5 million in 2026.
- Business Quant data shows AMLX's Operating Leases at $4.5 million in Q1 2026, $4.7 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Amylyx Pharmaceuticals | 4.37 Bn | 4.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.25 Mn |
| Mar 31, 2026 | 4.48 Mn |
| Dec 31, 2025 | 4.70 Mn |
| Sep 30, 2025 | 4.95 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 327,000.00 |
| Dec 31, 2024 | 463,000.00 |
| Sep 30, 2024 | 5.10 Mn |
| Jun 30, 2024 | 772,000.00 |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 1.98 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | 3.14 Mn |
| Mar 31, 2023 | 3.69 Mn |
| Dec 31, 2022 | 4.24 Mn |
| Sep 30, 2022 | 4.77 Mn |
| Jun 30, 2022 | 5.29 Mn |
| Mar 31, 2022 | 5.79 Mn |